Glenmark Life Sciences Ltd Q1 FY2025 PAT increases QOQ to Rs. 111.48 crores

Glenmark Life Sciences Ltd has reported Standalone financial results for the period ended June 30, 2024.

Financial Results (Q1 FY2025) - QoQ Comparison

The company has reported total income of Rs. 594.109 crores during the period ended June 30, 2024 as compared to Rs. 539.728 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs. 111.483 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. 97.937 crores for the period ended March 31, 2024.

The company has reported EPS of Rs. 9.08 for the period ended June 30, 2024 as compared to Rs. 7.97 for the period ended March 31, 2024.

Financials	Q1 FY2025	Q4 FY2024	% Change
Total Income	₹ 594.109 crs	₹539.728 crs	10.08%
Net Profit	₹111.483 crs	₹97.937 crs	13.83%
EPS	₹9.08	₹7.97	13.93%

Financial Results (Q1 FY2025) - YoY Comparison

The company has reported total income of Rs. 594.109 crores during the period ended June 30, 2024 as compared to Rs.580.301 crores during the period ended June 30, 2023.

The company has posted net profit / (loss) of Rs.111.483 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.135.450 crores for the period ended June 30, 2023.

The company has reported EPS of Rs.9.08 for the period ended June 30, 2024 as compared to Rs.11.05 for the period ended June 30, 2023.

Financials	Q1 FY2025	Q1 FY2024	% Change
Total Income	₹ 594.109 crs	₹580.301 crs	2.38%
Net Profit	₹111.483 crs	₹135.450 crs	-17.69%
EPS	₹9.08	₹11.05	-17.83%

Shares of Glenmark Life Sciences Ltd was last trading in BSE at Rs. 853.35 as compared to the previous close of Rs. 852.95. The total number of shares traded during the day was 11195 in over 862 trades.

The stock hit an intraday high of Rs. 868.00 and intraday low of 840.10. The net turnover during the day was Rs. 9571252.00.

Source : Equity Bulls

Keywords

GlenmarkLifeSciences Q1FY25 FY2025 Q1FY2025 ResultUpdate GLS